Bain Capital has emerged as the frontrunner to acquire Vitabiotics, as rival bidders TPG Capital and EQT exit the process, potentially lowe...

Mounjaro, the star pharmaceutical from Eli Lilly, is experiencing a downturn in sales across India. This slump can be attributed to competi...

Markets experienced a sharp sell-off on Monday's monthly expiry day, with the Nifty closing near 22,331. Key companies like IndiGo, Bharti ...

Lupin said it has inked a pact to acquire five drug brands from Italian firm Menarini for Rs 101 crore. The company has signed an agreement...

Shares of Lupin closed at Rs 737, up marginally by 0.02 per cent, on Thursday.

Boehringer Ingelheim will continue to sell its linagliptin under the brand names Trajenta (monotherapy) and TrajentaDuo (fixed-dose combina...

A day after announcing its biggest acquisition deal of $880 million, Lupin today said it will buy Germany-based Temmler Pharma's specialty ...

Homegrown drug major Lupin is looking to acquire companies and launch new products in the domestic market as it aims to scale up its Indian...

As per the strategic distribution pact inked between the two companies, Mumbai-based Lupin will launch LG Life Sciences' Insulin Glargine.

Lupin has inked a licensing pact with US-based pharma firm Romark Laboratories to market the latter's diarrhoea treatment drug 'Alinia'.

The Mumbai-based firm is adopting a three-pronged approach in its acquisition strategy, which also includes the domestic market.

The National Stock Exchange (NSE) today announced the inclusion of Lupin and UltraTech Cement in NSE 50-share index Nifty.

Lupin has received approval from the US health regulator to market its generic Suprax capsules, used for treating bacterial infections.

Lupin has received approval from USFDA to sell 'LoSeasonique' tablets, an oral contraceptive drug, in the American mkt.

Mumbai-based pharmaceutical firm Lupin is gearing to tap opportunities to the tune of up to $200 million in the US oral contraceptives mark...

Lupin, one of India’s largest pharma companies, on Thursday said it has signed an agreement with mid sized firm Natco to market the generic...

Drug maker Lupin Ltd on Thursday said it has acquired the pharmaceutical business of Rubamin group, for an undisclosed amount.